Connect with us

Legal & Regulation

CannaRegs Debuts First CBD Hemp Regulatory and Taxation Platform

Published

on

CannaRegs Debuts First CBD Hemp Regulatory and Taxation Platform
  • CannaRegs will help companies learn the necessary regulations to maintain compliance.
  • Their services will be available at the municipal, state, and federal levels.

CannaRegs Inc established itself as the first tech platform for cannabis regulations and taxation for the industry, focusing on the municipal, state, and federal level. Now, according to a press release by PR Newswire, the platform has decided to account coverage for hemp and CBD for each of the 50 states. Presently, CannaRegs offers the most comprehensive legal reports for cannabis in the entire country and has continually been a helpful resource to hundreds of businesses.

With this new expansion, CannaRegs provides the tools that businesses, manufacturers, and other major players in the industry need to keep compliance with the current laws.

There will be legal teams available to secure real-time documents for local and federal announcements, as well as feed schedules, filing instructions, ballot measures, and enforcement of the laws. Businesses will be able to gain details about various areas of interest, like zoning, banking, safety, and more.

Amanda Ostrowitz, the founder and CEO of CannaReg, commented that the demand by consumers for hemp and CBD products has been pivotal for the rise of the industry’s value. She noted that the company “saw the endless opportunities” to help other companies to maintain compliance in this complicated space.

Continuing, Ostrowitz said:

“We have a brilliant team of lawyers and researchers that are committed to making CannaRegs a reliable one stop shop for all businesses interested in entering the CBD market. We take a personal and local approach to legal guidance and are proud to now serve businesses in every stated.”

Ostrowitz’s former experience as a Federal Reserve Banking attorney opened her yes to the need for access to regulatory data in this industry, especially concerning the highly regulated and hyper local market. RegTechnology preceded the launch of CannaRegs in 2014, which Ostrowitz used to help build CannaRegs as the first vertical market served.

The CannaRegs platform features algorithms with machine learning technology, which have been backed and edited by a legal team to learn fact-based information about the guidelines involving cannabis. However, this opportunity creates a way to expand to other industries that could benefit from RegsTechnology, like home sharing and transit.

To learn more about CannaRegs, visit www.cannaregs.com.

Lin YC is known as a magnetic mama and brings a wide array of skillsets, knowledge and entertainment to the TOC team. With a Bachelor’s Degree in Philosophy, from her college student starting blocks as a writer to now being featured on LiveStrong, TheNest, eHow, Leaf.tv and Synonym.com, Lin is a true talent for specializing in health, beauty, fitness, weight loss and alternative medicines such as hemp.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.